GB Patent

GB0129260D0 — Pharmaceutical compositions and their uses

Assigned to Eisai London Research Laboratories Ltd · Expires 2002-01-23 · 24y expired

What this patent protects

The present invention relates to compositions comprising 1,2-dihydropiridin-2-one compounds and an immunoregulatory or anti-inflammatory agent. The compositions are useful for the prevention or the treatment of neurodegenerative diseases, for example demyelinating disorders.

USPTO Abstract

The present invention relates to compositions comprising 1,2-dihydropiridin-2-one compounds and an immunoregulatory or anti-inflammatory agent. The compositions are useful for the prevention or the treatment of neurodegenerative diseases, for example demyelinating disorders.

Drugs covered by this patent

Patent Metadata

Patent number
GB0129260D0
Jurisdiction
GB
Classification
—
Expires
2002-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Eisai London Research Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.